The Diabetic Esrd Patient: Specific Needs

Bloembergen W.E. , Port F.K. , Mauger E.A. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177–83.

Bloembergen W.E. , Port F.K. , Mauger E.A. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184–91.

Held P.J. , Port F.K. , Turenne M.N. Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163–9.

Zimmerman S.W. , Oxton L.L. , Bidwell D. Longterm outcome of diabetic patients receiving peritoneal dialysis. Perit Dial Int 1996; 16: 63–8.

Ritz E. , Stefenski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27: 167–94.

Warram J.H. , Laffel L.M. , Valsavia P. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991; 329: 1988–92.

Pritchard S. From a presentation at the 1996 conference on peritoneal dialysis. Seattle, W A.

Wakeen M. , Zimmerman S.W. , Bidwell D. Peripheral vascular disease in diabetic patients on PD receiving RHU-erythropoietin (Abstract). J Am Soc Nephrol 1993; 4: 420.

Abdel-Rahman E. , Wakeen M. , Zimmerman S.W. Characteristics of long-term peritoneal dialysis survivors (Abstract). J Am Soc Nephrol 1995; 6: 516.

Glasson Ph , Favre H. , Vallotton M.B. Response of blood pressure and the renin-angiotensin-aldosterone system to chronic ambulatory peritoneal dialysis in hypertensive end-stage renal failure. Clin Sci 1982; 63: 207s–209s.

Zager P.G. , Spalding C.T. , Frey H.J. Plasma levels of adrenocortical steroids in CAPD and hemodialysis patients. Perit Dial Bull 1984; 4(3)(Suppl): S88–91.

Jung R.T. , Shetty P.S. , Barrand M. Role of catecholamines in hypotensive response to dieting. Br Med J 1979; 1: 12–13.

Landsberg L. , Young J.B. Fasting, feeding and regulation of the sympathetic nervous system. N EnglJ Med 1978; 298: 1295–301.